CRISPR Gene Editing: Disruptive Technology & Emerging Markets Since the discovery that our genes hold the keys to our health, the race has been on to find a precise method to edit our genomes. CRISPR provides the tools to precisely edit genomes with unparalleled simplicity and flexibility, resulting in the potential for a revolutionary step towards curing hereditary disorders and correcting mutations that cause cancer. This breakthrough gene editing technology is barely 3 years old, yet it has already attracted tens of millions of dollars from investors, inspiring a multitude of exciting biotech startups. Join us for what is certain to be an informative and inspiring discussion about how entrepreneurs, academics and industry professionals can join in with the battle to exploit the biggest biotech discovery of the decade. We are delighted to have secured the following speakers, whose contributions promise to make this an event of universal interest and one not to be missed: Exclusive Speakers: Prof Tudor Fulga Associate Professor of Genome Biology, University of Oxford Lorenz Mayr Vice President & Global head, Reagents & Assay Development, Astra Zeneca Edward Perello CBO and co-founder of Desktop Genetics Eric Rhodes SVP & CTO of Horizon Discovery Phillip Webber Partner at Dehns (Patents & Trademark Attorneys) Join us for our extended networking and drinks reception. After the discussions there will be the opportunity to engage with our high profile speakers, sponsors and audience members in a less formal setting. Don’t miss this opportunity to join over 200 scientists and entrepreneurs for this major event. Attendance is FREE to all but prior registration is required (enter places to sign up). For details, link here:

Get in touch

14 + 14 =

Copyright © 2020 Enterprising Oxford | Site by Herd